High-rolling investors have positioned themselves bearish on ADMA Biologics (NASDAQ:ADMA), and it's important for retail traders to take note.This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in ADMA often signals that someone has privileged information.

Today, Benzinga's options scanner spotted 14 options trades for ADMA Biologics. This is not a typical pattern.

The sentiment among these major traders is split, with 21% bullish and 71% bearish. Among all the options we identified, there was one put, amounting to...